Inventor · disambiguated record
Shoufeng Li
Also filed as: LI SHOUFENG · LI SR SHOUFENG
15 granted patents·18 pending applications·56 citations·filing 2004–2025
90Inventor score
Files withSHANGHAI AUCTA PHARMACEUTICALS CO LTD9LI SHOUFENG4AZRIA MOISE3NOVARTIS AG3SPERO THERAPEUTICS INC2
Top patents by PatentIndex Score
33 records- 0193US11447456B1Crystalline form of lamotrigine hydrate, method for preparing the same and composition comprising the sameSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2021·Granted Sep 20, 2022·3 cites·19 claims
- 0289US11337943B2Lacosamide pharmaceutical composition and dosage form thereofSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2021·Granted May 24, 2022·4 cites·23 claims
- 0388US10653626B2Powder for oral suspension containing lamotrigineSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2018·Granted May 19, 2020·5 cites·18 claims
- 0486US12042474B2Lacosamide pharmaceutical composition and dosage form thereofSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2023·Granted Jul 23, 2024·1 cites·21 claims
- 0583US9301957B2Immediate release 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-YL)-3-(trifluoromethyl)phenyl] benzamide formulationBHARDWAJ UPKAR·Filed 2014·Granted Apr 5, 2016·16 cites·8 claims
- 0680US8800075B2Spring loaded docking mechanismVAN LEYEN JAN CHRISTOPHER·Filed 2011·Granted Aug 12, 2014·13 cites·15 claims
- 0776US8765675B2Use of calcitonin in osteoarthritisAZRIA MOISE·Filed 2010·Granted Jul 1, 2014·3 cites·8 claims
- 0876US7749954B2Use of calcitonin in osteoarthritisNOVARTIS AG·Filed 2004·Granted Jul 6, 2010·7 cites·11 claims
- 0973US8435946B2Orally dosed pharmaceutical compositions comprising a delivery agent in micronized formLI SHOUFENG·Filed 2008·Granted May 7, 2013·2 cites·12 claims
- 1072US8748383B2Method for treating bone related diseases and calcium disordersLI SHOUFENG·Filed 2013·Granted Jun 10, 2014·2 cites·10 claims
- 1170US2025025433A1Lacosamide pharmaceutical composition and dosage form thereofSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1267US2025009718A1Tebipenem pivoxil immediate and modified release oral dosage formsSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1364US11883374B2Lacosamide pharmaceutical composition and dosage form thereofSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1461US2012093939A1Oral formulationsPAYNE ADAM·Filed 2009·Application pending·0 cites
- 1557US12226403B2Tebipenem pivoxil immediate and modified release oral dosage formsSPERO THERAPEUTICS INC·Filed 2017·Granted Feb 18, 2025·0 cites·16 claims
- 1657US2014271735A1Use of calcitonin in osteoarthritisNOVARTIS AG·Filed 2014·Application pending·0 cites
- 1757US2011092515A1Melt granulation processQIU ZHIHUI·Filed 2009·Application pending·0 cites
- 1856US11813250B2Topical formulations containing mTOR inhibitorsSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2022·Granted Nov 14, 2023·0 cites·20 claims
- 1956US2021401748A1Powder for oral suspension containing lamotrigineAZURITY PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2053US2008255048A1Pharmaceutical CompositionAZRIA MOISE·Filed 2006·Application pending·0 cites
- 2151US2007065505A1Orally dosed pharmaceutical compositions comprising a delivery agent in micronized formLI SHOUFENG·Filed 2004·Application pending·0 cites
- 2250US9622975B2Pharmaceutical compositionNOVARTIS AG·Filed 2015·Granted Apr 18, 2017·0 cites·8 claims
- 2349US2009023754A1Modified release famciclovir pharmaceutical compositionsLEE WAI YIP·Filed 2006·Application pending·0 cites
- 2447US2011218148A1Pharmaceutical compositionAZRIA MOISE·Filed 2011·Application pending·0 cites
- 2545US2019240143A1Sustained Release Pharmaceutical Dosage Form of EntecavirAUCTA PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 2643US2025177332A1Pharmaceutical dosage form of lacosamideSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 2742US12478587B1Formulation for lacosamideSHANGHAI AUCTA PHARMACEUTICALS CO LTD·Filed 2025·Granted Nov 25, 2025·0 cites·19 claims
- 2839US2010247645A1Pharmaceutical combination of aliskiren and valsartanCURDY CATHERINE·Filed 2008·Application pending·0 cites
- 2938US2013245061A1Pharmaceutical compositionsCAO YU·Filed 2011·Application pending·0 cites
- 3038US2010209480A1Galenical formulations of organic compoundsALTENBURGER RALF·Filed 2008·Application pending·0 cites
- 3134US2015273070A1Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl-1h-imidazol-1-yl)-3-(triflouoromethyl)phenyl] benzamide solubilized using organic acidsLI SHOUFENG·Filed 2012·Application pending·0 cites
- 3226US2012009257A1Galenical Formulations of a Fixed Dose Combination of Valsartan and AliskirenGHOSH INDRAJIT·Filed 2010·Application pending·0 cites
- 3325US2012003308A1Pharmaceutical Composition Comprising AliskirenBOSE SONALI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shoufeng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →